Dunvegan Associates’s DaVita DVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
$37K Sell
530
-170
-24% -$12.5K 0.04% 111
2015
Q3
$51K Sell
700
-136
-16% -$10.5K 0.06% 92
2015
Q2
$66K Sell
836
-2,340
-74% -$192K 0.07% 80
2015
Q1
$258K Hold
3,176
0.23% 63
2014
Q4
$241K Sell
3,176
-180
-5% -$13.6K 0.21% 64
2014
Q3
$245K Hold
3,356
0.22% 50
2014
Q2
$243K Hold
3,356
0.2% 52
2014
Q1
$231K Hold
3,356
0.19% 52
2013
Q4
$213K Sell
3,356
-346
-9% -$20.3K 0.18% 63
2013
Q3
$211K Hold
3,702
0.16% 72
2013
Q2
$224K Buy
+3,702
New +$231K 0.17% 68

Other funds holding DVA

Dunvegan Associates's DVA Position: Q4 2015 in Review

Dunvegan Associates reduced its DaVita (DVA) stake by 24% in Q4 2015, selling an estimated $12.5K and leaving 530 shares worth $37K. The position accounts for 0.04% of the portfolio, ranked #111.

Dunvegan Associates first reported a position in DVA in Q2 2013 and has held it in 11 quarters since. The position peaked at $258K in Q1 2015. 503 funds tracked by Wall St. Rank hold DVA as of Q4 2015.

  • Dunvegan Associates held 530 shares of DaVita worth $37K as of Q4 2015.
  • Dunvegan Associates sold 170 DaVita shares in Q4 2015, an estimated $12.5K.
  • DaVita made up 0.04% of Dunvegan Associates's portfolio in Q4 2015, its #111 holding.
  • Dunvegan Associates first reported a position in DaVita in Q2 2013 and has held it in 11 quarters since.
  • Dunvegan Associates's DaVita position peaked at $258K in Q1 2015.
  • 503 funds tracked by Wall St. Rank held DaVita as of Q4 2015.

Based on Dunvegan Associates's 13F filing for Q4 2015, filed 28 Apr 2017.